PATENT CLAIM ANALYSIS

Application Number: 16298504
Application Type: Utility
Filing Date: 2019-03
Publication Date: 2019-07
Patent Classification: ["514", "019500"]

Abstract:
Pharmaceutical compositions and kits including a tyrosine hydroxylase inhibitor; melanin, a melanin promoter, or a combination thereof; a p450 3A4 promoter; and a leucine aminopeptidase inhibitor are provided. Also provided are methods of treating cancer in a subject, comprising administering an effective amount of a tyrosine hydroxylase inhibitor, a melanin promoter, a p450 3A4 promoter, and a leucine aminopeptidase inhibitor to the subject in need thereof. Also provided are methods of reducing cell proliferation in a subject comprising administering an effective amount of a tyrosine hydroxylase inhibitor, a melanin promoter, a p450 3A4 promoter, and a leucine aminopeptidase inhibitor to the subject in need thereof.

Claim (Index 2):
The method of  claim 1 , wherein each of said tyrosine hydroxylase inhibitor, said melanin, melanin promoter, or combination of melanin, methoxsalen and melanotan II; said p450 3A4 promoter; and said leucine aminopeptidase inhibitor is administered to said patient within a 24 hour period.

Metadata:
- Claim Count in Document: 7.0
- Percentile: 99.0
- Lexical Diversity: 2.92683
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14750877', '13371076', '15351966', '15158679', '15158712']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8221285140235282
- 35 USC 102 Novelty (BERT): 0.6140724581307732
- Combined Prediction Score: 0.8013229084342527
- Mean Citation Score: 522.244096
- Max Citation Score: 524.9393299999998
- Similarity Product: 519.2726426832859

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test